These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 74269)

  • 21. Androgen receptors in benign and malignant prostatic tissue.
    Lakey WH; Bruchovsky N; Callaway T; Comeau T; Lieskovsky G; Rennie P; Shnitka T; Wilkin P
    Trans Am Assoc Genitourin Surg; 1979; 71():19-22. PubMed ID: 94714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-androgen TSAA-291. VI. Effects of the anti-androgen TSAA-291 and its related compounds on the in vitro formation of 5 alpha-DHT-receptor complex in the cytosol of rat ventral prostates.
    Sudo K; Yoshida K; Nakayama R
    Acta Endocrinol Suppl (Copenh); 1979; 229():82-99. PubMed ID: 294109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen regulation of rat prostate androgen receptor.
    Bouton MM; Pornin C; Grandadam JA
    J Steroid Biochem; 1981 Dec; 15():403-8. PubMed ID: 7339268
    [No Abstract]   [Full Text] [Related]  

  • 24. Action of a novel nonsteroidal antiandrogen, AA560.
    Shida K; Yamanaka H; Koya A; Wakabayashi K; Mori H; Shibata K; Shimazawa E
    Endocrinol Jpn; 1980 Feb; 27(1):69-76. PubMed ID: 6156070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen receptor binding and antiandrogenic activity of some 4,5-secoandrostanes and ring B cyclopropanoandrostanes.
    Stárka L; Hampl R; Kasal A; Kohout L
    J Steroid Biochem; 1982 Sep; 17(3):331-4. PubMed ID: 6215537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific interaction of radioactive anti-androgen TSAA-291 with androgen receptor in rat prostates.
    Sudo K; Yoshida K; Nakayama R
    Acta Endocrinol (Copenh); 1982 Jul; 100(3):473-80. PubMed ID: 6214136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of sodium molybdate on cytosolic androgen receptors in rat prostate.
    Gaubert CM; Tremblay RR; Dubé JY
    J Steroid Biochem; 1980 Aug; 13(8):931-7. PubMed ID: 6970303
    [No Abstract]   [Full Text] [Related]  

  • 28. Action of a non-steroid anti-androgen, RU 23908, in peripheral and central tissues.
    Raynaud JP; Bonne C; Bouton MM; Lagace L; Labrie F
    J Steroid Biochem; 1979 Jul; 11(1A):93-9. PubMed ID: 385986
    [No Abstract]   [Full Text] [Related]  

  • 29. The effects of histamine H2 receptor antagonists on androgen action in vivo and dihydrotestosterone binding to the rat prostate androgen receptor in vitro.
    Sivelle PC; Underwood AH; Jelly JA
    Biochem Pharmacol; 1982 Mar; 31(5):677-84. PubMed ID: 6123322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific androgen binding in the kidney and estrogen-dependent renal carcinoma of the Syrian hamster.
    Li JJ; Cuthbertson TL; Li SA
    Endocrinology; 1977 Oct; 101(4):1006-15. PubMed ID: 908261
    [No Abstract]   [Full Text] [Related]  

  • 31. Sex-specific action of antiandrogens on androgen induced changes in hepatic microsomal 3 beta-hydroxysteroid dehydrogenase and 5 alpha-reductase activity in the rat.
    Lax ER; Schriefers H
    Acta Endocrinol (Copenh); 1981 Oct; 98(2):261-6. PubMed ID: 6457494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flutamide and cyproterone acetate exert agonist effects: induction of androgen receptor-dependent neuroprotection.
    Nguyen TV; Yao M; Pike CJ
    Endocrinology; 2007 Jun; 148(6):2936-43. PubMed ID: 17347309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of androgen-receptor interaction in mouse prostate gland cytosol by divalent metal ions.
    Donovan MP; Schein LG; Thomas JA
    Mol Pharmacol; 1980 Mar; 17(2):156-62. PubMed ID: 7393202
    [No Abstract]   [Full Text] [Related]  

  • 34. The cellular mechanism of the antiandrogenic action of nomegestrol acetate, a new 19-nor progestagen, on the rat prostate.
    Botella J; Paris J; Lahlou B
    Acta Endocrinol (Copenh); 1987 Aug; 115(4):544-50. PubMed ID: 3630545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of androgen binding in human foreskin fibroblasts by antiandrogens.
    Brown TR; Rothwell SW; Sultan C; Migeon CJ
    Steroids; 1981 Jun; 37(6):635-48. PubMed ID: 6457421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antiandrogenic effects of delta 1-testolactone (Teslac) in vivo in rats and in vitro in human cultured fibroblasts, rat mammary carcinoma cells, and rat prostate cytosol.
    Vigersky RA; Mozingo D; Eil C; Purohit V; Bruton J
    Endocrinology; 1982 Jan; 110(1):214-9. PubMed ID: 7053985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of the non-steroidal antiandrogen flutamide on neural receptor binding of testosterone and intermale aggressive behavior in mice.
    Clark CR; Nowell NW
    Psychoneuroendocrinology; 1980 Jan; 5(1):39-45. PubMed ID: 7190313
    [No Abstract]   [Full Text] [Related]  

  • 38. Analysis of the androgenic activity of synthetic "progestins" currently used for the treatment of prostate cancer.
    Labrie C; Cusan L; Plante M; Lapointe S; Labrie F
    J Steroid Biochem; 1987 Oct; 28(4):379-84. PubMed ID: 2444770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The nuclear uptake of androgen by human benign prostate in vitro: action of antiandrogens.
    Symes EK; Milroy EJ; Mainwaring WI
    J Urol; 1978 Aug; 120(2):180-3. PubMed ID: 671628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology of an antiandrogen, anandron, used as an adjuvant therapy in the treatment of prostate cancer.
    Moguilewsky M; Fiet J; Tournemine C; Raynaud JP
    J Steroid Biochem; 1986 Jan; 24(1):139-46. PubMed ID: 3009970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.